Lee Financial Co initiated a new position in UnitedHealth Group during the third quarter, acquiring 3,390 shares valued at approximately $1.17 million, according to its latest Form 13F filing. Brighton Jones LLC more than doubled its stake by purchasing an additional 28,231 shares in the fourth quarter, bringing its total to 44,249 shares valued at $22.38 million. Revolve Wealth Partners LLC raised its holding by 137.1%, adding 2,324 shares to reach a total of 4,019 shares worth $2.03 million. Other notable moves include CMT Capital Markets Trading GmbH’s new $340,000 stake in the second quarter, and Patriot Financial Group Insurance Agency LLC’s 42.5% increase to 5,312 shares valued at $1.66 million. Hedge funds and other institutions now own 87.86% of the outstanding shares.

Equity analysts maintain a generally positive outlook on UnitedHealth Group. Jefferies Financial Group retained its Buy rating while adjusting its target from $418 to $340. KeyCorp reaffirmed an Overweight rating, and TD Cowen nudged its target upward from $335 to $338 with a Hold rating. Oppenheimer continues to rate the company as Outperform despite lowering its target from $415 to $385. Zacks Research upgraded its view from Strong Sell to Hold. Of the 29 analysts covering the stock, 18 recommend Buy or Strong Buy, nine suggest Hold and two advise Sell, supporting a consensus Moderate Buy rating based on an average target of $376.75.

In its January quarter, UnitedHealth Group reported revenue of $113.22 billion, a 12.3% year-over-year increase, narrowly missing consensus estimates by $160 million. Adjusted earnings per share of $2.11 beat expectations by $0.02. Net margin stood at 2.69% and return on equity at 14.79%. For fiscal year 2026, management set EPS guidance of 17.75, while sell-side analysts project full-year EPS of 29.54, reflecting confidence in continued profitability despite near-term revenue headwinds.

UnitedHealth Group declared a quarterly dividend of $2.21, payable to shareholders of record on December 8 and representing an annualized yield of 3.1% with a payout ratio of 67.02%. On the balance sheet, the company maintains a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82, reflecting ample liquidity and moderate leverage as it funds ongoing investments across its UnitedHealthcare and Optum platforms.